RGEN (Repligen Corporation) Stock Financials & Earnings

RGENRepligen Corporation

Mkt Cap$7B

Revenue (TTM)$738M

Net Income (TTM)$49M

EPS (TTM)$0.85

Free Cash Flow (TTM)$91M

Gross Margin50.9%

Op. Margin7.6%

Net Margin6.6%

FCF Margin12.4%

P/S Ratio (TTM)9.5x

P/E Ratio (TTM)144.0x

YoY Rev Growth+16.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$165M	$84M	$14M
Q2 23	$159M	$80M	$19M
Q3 23	$141M	$37M	$5M
Q4 23	$156M	$68M	-$887K
Q1 24	$153M	$77M	$4M
Q2 24	$159M	$73M	$7M
Q3 24	$155M	$77M	-$8M
Q4 24	$168M	$39M	-$37M
Q1 25	$169M	$91M	$7M
Q2 25	$182M	$91M	$14M
Q3 25	$189M	$101M	$17M
Q4 25	$198M	$93M	$19M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$12M	$56M	$118K	—
Q2 23	$10M	—	—	$49M
Q3 23	$11M	—	—	$56M
Q4 23	$10M	—	—	$58M
Q1 24	$11M	$61M	$817K	—
Q2 24	$10M	—	—	$56M
Q3 24	$10M	—	—	$76M
Q4 24	$12M	—	—	$60M
Q1 25	$13M	—	—	$71M
Q2 25	$14M	—	—	$71M
Q3 25	$14M	—	—	$74M
Q4 25	$12M	—	—	$63M

Revenue Segments

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$517M	$101M	$618M
Q2 23	$604M	$0	$604M
Q3 23	$631M	$0	$631M
Q4 23	$751M	$0	$751M
Q1 24	$781M	$0	$781M
Q2 24	$809M	$0	$809M
Q3 24	$784M	$0	$784M
Q4 24	$757M	$0	$757M
Q1 25	$697M	$0	$697M
Q2 25	$709M	$0	$709M
Q3 25	$749M	$0	$749M
Q4 25	$566M	$202M	$768M

Shares Outstanding

Revenue Per Employee

Revenue / Employee